Aug 11, 2022 08:11AM
Jul 19, 2022 08:00AM
Jul 19, 2022 08:00AM
Mar 21, 2022 06:41AM
Jan 4, 2022 05:12AM
Jan 4, 2022 05:00AM
Jan 4, 2022 05:00AM Allena Pharmaceuticals Provides Clinical and Corporate Update
Dec 20, 2021 01:00AM
Nov 10, 2021 04:05PM
Nov 10, 2021 04:05PM
Nov 3, 2021 08:00AM
Nov 3, 2021 08:00AM
Nov 3, 2021 08:00AM
Sep 29, 2021 08:00AM Allena Pharmaceuticals Commences Dosing of Gout Patients in Second Phase 2a Trial of ALLN-346
Sep 29, 2021 08:00AM
Aug 10, 2021 04:30PM
Aug 10, 2021 04:30PM
Jul 14, 2021 05:00AM
Jul 13, 2021 11:43PM
Jul 13, 2021 11:43PM
Jul 12, 2021 08:04AM Allena Pharmaceuticals (ALNA) Provides Update on Clinical Development Programs
Jul 12, 2021 08:00AM
Jul 12, 2021 08:00AM
Jun 8, 2021 08:30AM
Jun 8, 2021 08:30AM
May 11, 2021 08:00AM
May 11, 2021 08:00AM
Apr 7, 2021 08:04AM Allena Pharmaceuticals (ALNA) Names Mark J. Fitzpatrick to Board
Apr 7, 2021 08:00AM
Apr 7, 2021 08:00AM
Mar 9, 2021 07:00AM
Mar 9, 2021 07:00AM
Dec 1, 2020 09:47PM
Dec 1, 2020 09:47PM
Dec 1, 2020 05:00PM Allena Pharmaceuticals (ALNA) Announces $10 Million Bought Deal Offering of Common Stock
Dec 1, 2020 05:00PM
Dec 1, 2020 05:00PM
Dec 1, 2020 08:01AM
Dec 1, 2020 08:00AM
Dec 1, 2020 08:00AM
Nov 30, 2020 08:01AM
Nov 30, 2020 08:00AM Allena Pharmaceuticals Announces Initial Data from Phase 1 Trial of ALLN-346
Nov 30, 2020 08:00AM
Nov 9, 2020 08:00AM
Nov 9, 2020 08:00AM
Oct 22, 2020 09:00AM
Aug 5, 2020 08:00AM
Aug 5, 2020 08:00AM
Jul 27, 2020 08:48PM Allena Pharmaceuticals Increases Previously Announced Bought Deal to $6.7 Million
Jul 27, 2020 08:48PM

322,134 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All